natur
transmiss
rout
three
felin
haemotrop
mycoplasma
three
haemotrop
mycoplasma
caus
agent
felin
infecti
anaemia
describ
cat
mycoplasma
haemof
mhf
candidatu
mycoplasma
haemominutum
cmhm
candidatu
mycoplasma
turicensi
cmt
recent
fourth
speci
similar
candidatu
haematoparvum
suggest
infect
cat
pathogen
potenti
felin
haemotrop
mycoplasma
isol
studi
date
vari
immunosuppress
preexist
retrovir
infect
may
potenti
sever
anaemia
diagnosi
felin
haemotrop
mycoplasma
aka
haemoplasma
limit
microscop
detect
agent
blood
smear
unreli
recent
sensit
pcr
assay
introduc
consid
gold
standard
detect
differenti
felin
haemoplasma
speci
use
pcr
worldwid
distribut
felin
haemotrop
mycoplasma
infect
document
date
commerci
routin
serolog
assay
avail
serodiagnost
depend
crude
mhf
antigen
recent
immunodomin
protein
mycoplasma
sui
porcin
haemoplasma
speci
identifi
surfacelocalis
dnak
analogu
natur
mode
felin
haemoplasma
transmiss
remain
controversi
experiment
transmiss
intraperiton
intraven
oral
inocul
infect
blood
success
howev
earli
studi
perform
prior
introduct
specif
molecular
assay
known
felin
haemoplasma
speci
studi
recent
blood
transfus
report
sourc
mhf
cmhm
infect
furthermor
bloodsuck
arthropod
may
involv
transmiss
felin
haemoplasma
almost
unf
ixod
spp
tick
collect
veget
switzerland
test
pcrneg
felin
haemoplasma
posit
result
cmhm
cmt
obtain
ixod
spp
rhipicephalu
spp
tick
collect
directli
anim
cmhm
dna
detect
unf
ixod
ovatu
tick
japan
suggest
transstadi
transmiss
cmhm
least
latter
tick
speci
moreov
mhf
cmhm
dna
detect
cat
flea
ctenocephalid
feli
collect
experiment
natur
infect
cat
flea
faec
transmiss
mhf
cmhm
via
c
feli
proven
recent
investig
shed
pattern
realtim
pcr
led
detect
cmt
dna
saliva
faec
nine
week
experiment
cmt
infect
studi
howev
mhf
cmhm
dna
detect
saliva
faec
natur
infect
cat
despit
high
blood
haemotrop
mycoplasma
load
recent
cmhm
mhf
detect
saliva
salivari
gland
experiment
infect
cat
thu
hypothesis
felin
haemoplasma
particularli
cmt
cmhm
could
transmit
direct
contact
social
aggress
via
saliva
hypothesi
support
gener
increas
felin
haemoplasma
infect
particularli
mhf
cmhm
cmt
infect
male
cat
moreov
earli
studi
report
histori
cat
biteassoci
abscess
increas
rel
risk
infect
haemotrop
mycoplasma
howev
particular
haemoplasma
speci
could
molecularli
differenti
time
studi
aim
present
studi
address
hypothesi
investig
possibl
direct
transmiss
cmt
cat
mimic
aggress
contact
cat
bite
saliva
blood
sampl
cmtinfect
cat
inocul
subcutan
recipi
cat
social
contact
cat
simul
oronas
oral
inocul
cat
monitor
follow
cmt
exposur
blood
sampl
assess
cmt
infect
use
sensit
realtim
pcr
novel
western
blot
assay
area
optim
etholog
condit
prior
start
experi
cat
clinic
examin
blood
serum
sampl
conjunctiv
oropharyng
rectal
swab
collect
verifi
spf
statu
cat
found
neg
sampl
test
realtim
taqman
pcr
rtpcr
describ
follow
blood
sampl
test
cmt
mhf
cmhm
felin
parvoviru
caliciviru
coronaviru
bartonella
hensela
felin
leukaemia
immunodefici
viru
proviru
conjunctiv
swab
test
felin
caliciviru
felin
chlamydophila
feli
oropharyng
swab
test
felin
caliciviru
felin
rectal
swab
test
felin
coronaviru
felin
parvoviru
addit
serum
sampl
test
neg
antibodi
felin
coronaviru
cat
bloodtyp
use
commerci
gel
column
techniqu
idgel
test
felin
ab
type
diam
ag
cressier
sur
morat
switzerland
cat
blood
type
two
cat
blood
type
b
two
latter
cat
sibl
three
castrat
adult
male
cat
year
age
infect
intraperiton
cmt
obtain
infecti
saliva
blood
sampl
amplificatori
cat
cat
x
z
ten
juvenil
cat
two
month
age
hous
two
group
cat
group
b
use
recipi
cat
transmiss
studi
follow
conclus
studi
three
amplificatori
cat
adopt
ten
recipi
cat
continu
remain
studi
cat
clinic
examin
perform
three
veterinarian
complet
haemogram
amplificatori
cat
perform
prior
prednisolon
treatment
prior
cmt
infect
daili
saliva
collect
sporad
week
pi
cat
x
week
pi
cat
z
saliva
swab
primella
migro
genossenschaftsbund
zurich
switzerland
collect
everi
day
blood
cat
blood
pcrposit
collect
larg
volum
saliva
ml
transmiss
studi
saliva
product
stimul
cat
x
subcutan
inject
neostigmin
valeant
pharmaceut
birsfelden
switzerland
mgkg
min
prior
ketaminemidazolam
narcosi
ketamin
mgkg
midazolam
mgkg
intramuscularli
ittigen
switzerlandroch
reinach
switzerland
saliva
sampl
divid
aliquot
inocul
pcr
sampl
inocul
kept
room
temperatur
administ
within
min
collect
sampl
pcr
store
use
edtaanticoagul
blood
sampl
serum
collect
pcr
analysi
haematolog
western
blot
ten
recipi
cat
prior
regularli
cmt
inocul
bodi
temperatur
bodi
weight
record
sampl
date
haemogram
perform
use
celldyn
abbott
baar
switzerland
pack
cell
volum
pcv
valu
quantil
refer
rang
clinic
laboratori
defin
ident
method
healthi
cat
consid
within
normal
rang
anaemia
defin
pcv
valu
modifi
wrightstain
blood
smear
ame
hema
tek
slide
stainer
bayer
zurich
switzerland
diffquickstain
medion
diagnost
dudingen
switzerland
smear
evalu
light
microscopi
cmt
three
amplificatori
cat
infect
intraperiton
administr
cmt
previous
describ
cat
x
z
receiv
copi
cmt
ml
infecti
heparinis
blood
preserv
dmso
sigmaaldrich
buch
switzerland
store
cmt
use
deriv
cmt
isol
previous
describ
cat
passag
passag
addit
spf
cat
administ
cat
x
thu
passag
twice
prior
inocul
cat
x
cat
z
origin
isol
passag
three
time
prior
inocul
three
cat
administ
two
dose
methylprednisolon
acet
intramuscularli
mgkg
depomedrol
pfizer
ag
zurich
switzerland
attempt
immunocompromis
cat
cat
x
inject
day
prior
cmt
inocul
cat
z
inject
day
prior
cmt
inocul
addit
begin
day
pi
cat
z
receiv
prednisolon
oral
mgkgd
streuli
pharma
ag
uznach
switzerland
day
peak
bacteraemia
cat
x
z
ml
blood
ml
bone
marrow
collect
bone
marrow
aspir
perform
proxim
humeru
use
rosenth
type
bone
marrow
aspir
needl
monoject
gaug
kendal
mansfield
usa
short
durat
gener
anaesthesia
analgesia
cat
administ
acepromazin
arovet
ag
zollikon
switzerland
mgkg
buprenorphin
essex
chemi
switzerland
mgkg
intramuscularli
follow
intraven
inject
propofol
freseniu
bad
homburg
germani
induct
mgkg
mainten
mgkg
everi
min
subsequ
three
amplificatori
cat
administ
antibiot
treatment
marbofloxacin
andor
doxycyclin
gmbh
switzerland
indic
figur
model
direct
transmiss
cmt
via
saliva
simul
aggress
social
contact
saliva
cmtposit
amplificatori
cat
inocul
oronas
subcutan
recipi
cat
within
min
collect
five
recipi
cat
group
expos
oronas
saliva
tab
one
drop
saliva
administ
nostril
cat
use
syring
remain
saliva
administ
oral
cat
receiv
cumul
dose
ml
saliva
contain
copi
cmt
period
day
inocul
took
place
day
sampl
administ
base
avail
volum
saliva
collect
amplificatori
cat
volum
pcrposit
transmit
sampl
rang
per
recipi
cat
day
aliquot
saliva
contain
copi
cmt
inocul
subcutan
five
recipi
cat
group
b
tab
b
inocul
b
unsuccess
cat
administ
prednisolon
attempt
immunocompromis
cat
prior
next
cmt
inocul
indic
tabl
ii
b
ii
develop
salivaassoci
abscess
necessit
termin
prednisolon
administr
group
b
cat
requir
treatment
amoxicillinclavulan
synulox
mgkg
everi
h
day
pfizer
ag
sinc
saliva
inocul
without
prednisolon
administr
lead
cmt
neg
infect
recipi
cat
determin
realtim
pcr
week
last
saliva
administr
cat
group
b
inocul
cmtposit
blood
tab
iii
b
iii
cat
group
administ
blood
contain
copi
cmt
tab
iii
cat
offer
blood
syring
voluntarili
lick
ingest
blood
reject
blood
observ
cat
remain
pcrneg
week
inocul
larger
blood
volum
contain
cmt
copi
tab
iv
cat
remain
pcrneg
week
follow
larger
dose
challeng
subcutan
cmt
copi
cmtposit
blood
tab
v
order
confirm
cat
could
infect
cmt
group
b
cat
receiv
cmt
copi
blood
subcutan
tab
b
iii
cat
remain
pcrneg
inocul
repeat
week
first
subcutan
inocul
tab
b
iv
total
nucleic
acid
tna
extract
edtaanticoagul
blood
bone
marrow
use
magna
pure
lc
total
nucleic
acid
isol
kit
roch
diagnost
sampl
store
prior
extract
tna
elut
elut
buffer
neg
extract
control
consist
phosphat
buffer
salin
prepar
batch
saliva
sampl
swab
pb
incub
min
tna
extract
previous
describ
tna
sampl
analys
quantifi
realtim
taqman
pcr
presenc
cmt
dna
previous
describ
water
use
neg
pcr
control
recombin
protein
mhf
use
antigen
bp
fragment
ligat
xa
vector
qiagen
hombrechtikon
switzerland
transform
escherichia
coli
cell
invitrogen
basel
switzerland
protein
product
sdspage
immunoblot
perform
describ
previous
follow
modif
protein
express
induc
use
mm
iptg
e
coli
cultur
grown
lb
medium
contain
lgml
ampicillin
protein
purifi
nickel
affin
chromatographi
qiagen
chelat
sepharos
ge
health
care
bioscienc
uppsala
sweden
total
lg
antigen
use
per
stripe
felin
sampl
incub
dilut
immunoreact
protein
visualis
use
horseradish
peroxidaseconjug
goat
anticat
igg
sigmaaldrich
substrat
western
blot
evalu
sampl
three
spf
cat
infect
mhf
week
pi
cmhm
week
pi
cmt
week
pi
addit
sampl
five
haemoplasmafre
spf
cat
studi
seroconvers
follow
cmt
infect
three
amplificatori
ten
recipi
cat
test
prior
variou
timepoint
follow
cmt
exposur
statist
analys
perform
use
excel
addin
analyseit
analyseit
softwar
leed
uk
graphpad
prism
graphpad
softwar
san
diego
ca
usa
correl
analys
spearman
rank
correl
test
use
p
continu
variabl
analys
signific
differ
among
three
group
use
kruskalw
test
p
kw
dunn
multipl
comparison
posttest
comparison
two
group
made
use
mannwhitney
utest
p
mwu
pvalu
less
consid
signific
cmt
dna
detect
blood
sampl
salivari
swab
bone
marrow
collect
three
amplificatori
cat
fig
tna
extract
control
neg
pcr
control
pcrneg
cat
x
z
becam
blood
pcrposit
first
sampl
date
day
pi
respect
cat
becam
blood
pcrposit
day
pi
fig
peak
cmt
blood
load
reach
copiesml
bone
marrow
load
reach
copiesml
cat
remain
blood
pcrposit
treatment
see
cat
x
z
becam
anaem
minimum
pcv
day
pi
respect
fig
combin
data
three
cat
analys
haemoplasma
load
invers
correl
pcv
valu
r
p
erythrocyt
count
r
p
haemoglobin
valu
r
p
mild
loss
appetit
apathi
observ
three
cat
week
infect
posit
pcr
result
obtain
salivari
swab
collect
three
amplificatori
cat
peak
bacteraemia
fig
cmt
load
pcrposit
saliva
sampl
rang
copiesml
saliva
median
copiesml
subcutan
exposur
cmt
dnacontain
saliva
evid
cmt
infect
detect
recipi
cat
attempt
transmiss
cmt
via
saliva
determin
realtim
pcr
result
independ
prior
prednisolon
administr
ten
cat
tab
ii
ii
b
b
ii
subcutan
exposur
cmtcontain
blood
neither
low
dose
cmt
copi
high
dose
cmt
copi
oral
exposur
cmtposit
blood
led
infect
five
recipi
cat
group
tab
ii
iii
iv
cat
subsequ
group
b
recipi
cat
subcutan
inocul
cmtposit
blood
tab
b
iii
becam
pcrposit
averag
day
rang
day
peak
blood
load
rang
copiesml
tab
ii
fig
one
cat
cat
administ
antibiot
treatment
salivaassoci
abscess
day
prior
blood
inocul
remain
pcrneg
throughout
studi
cat
one
two
cat
blood
type
b
clinic
sign
infect
eg
fever
weightloss
absent
ten
recipi
cat
anaemia
observ
one
case
cat
group
pcv
drop
coincid
peak
cmt
load
copiesml
fig
similarli
peak
bacteraemia
cat
accompani
slight
decreas
pcv
group
fig
signific
differ
maximum
cmt
blood
load
observ
amplificatori
cat
cat
group
cat
group
b
p
kw
intraperiton
infect
cat
show
significantli
higher
bacteri
load
compar
subcutan
expos
cat
group
v
b
iii
p
mwu
signific
differ
also
found
length
time
cmt
exposur
first
posit
pcr
result
three
group
p
kw
cat
infect
intraperiton
becam
pcrposit
earlier
cmt
exposur
cat
infect
subcutan
p
mwu
addit
cat
infect
intraperiton
display
lower
minimum
pcv
valu
cat
expos
subcutan
p
mwu
cmt
pcrposit
cat
n
includ
analys
minimum
pcv
valu
significantli
neg
correl
maximum
cmt
blood
load
r
p
fig
moreov
minimum
pcv
significantli
posit
correl
length
time
cmt
inocul
first
posit
pcr
blood
result
r
p
fig
peak
cmt
blood
load
significantli
neg
correl
length
time
cmt
inocul
first
posit
pcr
result
r
p
fig
doxycyclin
treatment
three
cat
x
z
becam
persist
blood
pcrneg
end
studi
week
pi
nine
pcrposit
recipi
cat
administ
antibiot
becam
pcrneg
within
week
pi
remain
neg
end
observ
period
week
later
mhf
fragment
recognis
sera
cat
infect
mhf
cmhm
cmt
sera
five
haemoplasmafre
spf
cat
react
antigen
fig
cat
use
cmt
transmiss
studi
seroneg
prior
cmt
exposur
fig
cmt
challeng
cat
becam
seroposit
base
western
blot
analysi
fig
weekli
serum
sampl
demonstr
seroconvers
major
cat
week
pi
fig
cat
infect
intraperiton
cmt
demonstr
seroconvers
week
pi
fig
remain
seroposit
week
pi
thereaft
band
observ
western
blot
decreas
intens
andor
vanish
time
group
cat
seroconvert
week
exposur
v
fig
one
cat
cat
fig
alreadi
seroconvert
week
oronas
saliva
inocul
ii
cat
cat
blood
type
b
group
b
four
pcrposit
cat
also
seroconvert
follow
cmt
exposur
tab
ii
b
iii
week
pi
fig
one
cat
cat
fig
remain
pcrneg
throughout
studi
subsequ
seroconvert
week
second
subcutan
inocul
cmt
copi
tab
ii
b
iv
recipi
cat
remain
seroposit
end
studi
none
infect
cat
regardless
cmt
blood
load
show
characterist
haemoplasmalik
inclus
could
clearli
identifi
light
microscopi
stain
blood
smear
first
experiment
studi
investig
direct
transmiss
cmt
eg
transmiss
via
social
aggress
contact
cat
use
sensit
specif
realtim
pcr
assay
none
cat
oronas
oral
expos
saliva
blood
cmtinfect
cat
becam
blood
pcrposit
true
follow
subcutan
inocul
saliva
contrast
subcutan
exposur
infecti
blood
result
infect
previou
studi
shed
cmt
dna
via
saliva
demonstr
two
experiment
infect
cat
earli
late
phase
infect
present
studi
cmt
dna
saliva
found
three
monitor
cat
although
cmt
use
present
studi
passag
vivo
differ
observ
cours
kinet
infect
shed
pattern
compar
origin
studi
cmt
infect
led
anaemia
prednisolonetr
cat
cat
receiv
highest
dose
prednisolon
cat
z
show
shortest
incub
period
highest
blood
load
lowest
pcv
valu
among
three
amplificatori
cat
invers
associ
cmt
load
pcv
valu
found
previous
report
two
cat
experiment
infect
cmt
due
unavail
cultur
assay
could
determin
vitro
whether
cmt
dna
saliva
infect
cat
repres
viabl
organ
accord
find
howev
cmtposit
saliva
pose
major
risk
infect
cat
nonetheless
one
cat
cat
seroconvert
follow
oral
inocul
cmtposit
saliva
thu
cat
appear
least
cmt
antigen
must
transmit
via
saliva
result
cmt
replic
must
detect
limit
pcr
assay
occur
tissu
peripher
blood
unlik
cmt
load
saliva
sampl
low
result
posit
pcr
result
given
copi
number
administ
blood
suffici
infect
cat
follow
subcutan
inocul
even
without
preexist
prednisolon
treatment
cmtposit
blood
found
infecti
administ
intraven
intraperiton
subcutan
present
studi
contrast
oral
inocul
cmtposit
blood
result
infect
present
studi
earli
studi
inocul
ml
blood
haemoplasmainfect
cat
determin
microscopi
haemoplasma
speci
molecularli
determin
result
infect
recipi
cat
opinion
howev
seem
highli
unlik
cat
would
expos
larg
volum
infecti
blood
natur
condit
therefor
present
studi
exceed
infecti
blood
collect
peak
bacteraemia
aim
simul
natur
process
model
aggress
interact
subcutan
inocul
select
cat
inocul
littl
two
drop
cmtposit
blood
becam
infect
small
volum
blood
cmtposit
cat
could
transmit
recipi
cat
via
bite
moreov
volum
correspond
volum
report
consum
c
feli
per
day
haematophag
activ
experiment
studi
flea
transmiss
yet
conclus
role
c
feli
transmiss
haemoplasma
remain
unclear
differ
observ
amplificatori
recipi
cat
cours
cmt
infect
minimum
pcv
peak
cmt
load
incub
period
may
attribut
attempt
immunosuppress
also
differ
infect
rout
infect
dose
age
cat
determin
whether
factor
signific
influenc
infect
overal
shorter
incub
period
higher
cmt
load
lower
pcv
valu
eight
nine
cat
becam
pcrposit
subcutan
cmt
exposur
show
similar
infect
cours
becam
pcrposit
within
week
seroconvert
within
week
pi
within
week
follow
posit
bloodpcr
result
two
cat
remark
sibl
two
cat
present
studi
blood
type
b
one
cat
cat
alreadi
seroposit
time
subcutan
exposur
seroconvert
oronas
exposur
cmtposit
saliva
see
cat
becam
pcrposit
later
cours
infect
follow
subcutan
exposur
day
pi
develop
lower
peak
cmt
blood
load
copiesml
compar
eight
cat
median
peak
load
copiesml
second
blood
type
b
cat
cat
remain
blood
pcrneg
even
repeat
cmt
exposur
cat
subsequ
seroconvert
second
cmt
inocul
never
blood
pcrposit
oronas
exposur
cmt
antigen
result
immun
respons
cat
might
led
partial
protect
reduc
cmt
load
antibiot
treatment
cat
three
week
first
cmt
blood
inocul
may
influenc
cours
infect
altern
blood
type
two
cat
blood
type
b
genet
factor
may
play
role
suscept
cmt
howev
due
small
number
subject
present
studi
determin
cours
cmt
infect
describ
herein
ie
seroconvers
absenc
cmt
peripher
blood
detect
realtim
pcr
describ
previous
microscopi
blood
smear
diagnos
cmt
infect
recommend
consist
earlier
find
assum
inabl
detect
cmt
via
method
may
due
low
cmt
blood
load
found
significantli
lower
mhf
blood
load
even
peak
cmt
blood
load
copiesml
correspond
one
cmt
copi
per
erythrocyt
number
undetect
routin
light
microscopi
serolog
assay
describ
studi
base
fragment
mhf
detect
via
western
blot
demonstr
seroconvers
cat
expos
cmt
use
assay
two
seroposit
pcrneg
anim
identifi
among
cat
administ
antibiot
intens
western
blot
band
decreas
andor
vanish
time
ten
untreat
cat
remain
seroposit
antibiot
treatment
may
clear
cmt
blood
tissu
wherea
sequest
cmt
infect
may
led
continu
lowlevel
stimul
humour
immun
respons
untreat
cat
serolog
assay
describ
studi
may
excel
tool
investig
pathogenesi
haemoplasma
infect
conclus
result
indic
social
contact
share
food
dish
groom
cmtposit
cat
unlik
pose
risk
infect
cat
howev
hypothesi
partial
confirm
direct
transmiss
cmt
via
aggress
interact
eg
cat
bite
may
occur
recipi
cat
expos
small
volum
infecti
blood
